Scientists uncover key driver of treatment-resistant cancer: Genome-scrambling enzyme points to new treatments

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...

GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy

Patent Protects Novel Application of Gedeptin Therapy Across Multiple Solid Tumor Types; Supports Expansion of Gedeptin ...

GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer

Phase 1/2 Trial Confirms Safety With Repeated Dosing Supporting Further Development in Early-stage Disease and Combination Treatment Settings ATLANTA, GA - December 8, 2025 (NEWMEDIAWIRE) - GeoVax ...

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.